Evidence map›Paper›PMID 19321746›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma.

Stephan Mathas, Stephan Kreher, Karen J Meaburn, Korinna Jöhrens, Björn Lamprecht, Chalid Assaf, Wolfram Sterry, Marshall E Kadin, Masanori Daibata, Stefan Joos and 7 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 103 citations in OpenAlex.

  1. Review
  2. Article
  3. Role of Fra-2 in cancer.Cell death and differentiation · 2024
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Midkine-a Is Required for Cell Cycle Progression of Müller Glia during Neuronal Regeneration in the Vertebrate Retina.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  12. Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 3 countries.

Stephan MathasMax-Delbrück-Center for Molecular Medicine, Robert-Rössle-Strasse 10, 13125 Berlin, Germany. stephan.mathas@charite.de
Stephan Kreher
Karen J Meaburn
Korinna Jöhrens
Björn Lamprecht
Chalid Assaf
Wolfram Sterry
Marshall E Kadin
Masanori Daibata
Stefan Joos
Michael Hummel
Harald Stein
Martin Janz
Ioannis Anagnostopoulos
Evelin Schrock
Tom Misteli
Bernd Dörken
Charité - Universitätsmedizin Berlin · DEMax Delbrück Center · DEGerman Cancer Research Center · DEHarvard University · USKōchi University · JPNational Cancer Institute · USNational Institutes of Health · USTU Dresden · DE

Funding

Nuclear Architecture and DiseaseZIABC010309 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MISTELI, THOMAS A · 2009 to 2025
$39.8M
Nuclear architecture and gene expression Z01BC010309 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MISTELI, THOMAS A · 1999 to 2008
$3.6M
Intramural NIH HHS
6 · The paper itself

Abstract

Although the identification and characterization of translocations have rapidly increased, little is known about the mechanisms of how translocations occur in vivo. We used anaplastic large cell lymphoma (ALCL) with and without the characteristic t(2;5)(p23;q35) translocation to study the mechanisms of formation of translocations and of ALCL transformation. We report deregulation of several genes located near the ALCL translocation breakpoint, regardless of whether the tumor contains the t(2;5). The affected genes include the oncogenic transcription factor Fra2 (located on 2p23), the HLH protein Id2 (2p25), and the oncogenic tyrosine kinase CSF1-receptor (5q33.1). Their up-regulation promotes cell survival and repression of T cell-specific gene expression programs that are characteristic for ALCL. The deregulated genes are in spatial proximity within the nuclear space of t(2;5)-negative ALCL cells, facilitating their translocation on induction of double-strand breaks. These data suggest that deregulation of breakpoint-proximal genes occurs before the formation of translocations, and that aberrant transcriptional activity of genomic regions is linked to their propensity to undergo chromosomal translocations. Also, our data demonstrate that deregulation of breakpoint-proximal genes has a key role in ALCL.

Indexed as

Chromosome BreakageGene Expression Regulation, NeoplasticTranslocation, GeneticCell Line, TumorChromosomes, Human, Pair 2Chromosomes, Human, Pair 5Fos-Related Antigen-2Genome, HumanHumansInhibitor of Differentiation Protein 2Lymphoma, Large-Cell, AnaplasticReceptor, Macrophage Colony-Stimulating FactorTranscription, GeneticFOSL2 protein, humanFos-Related Antigen-2ID2 protein, humanInhibitor of Differentiation Protein 2Receptor, Macrophage Colony-Stimulating Factor

Identifiers

PMID19321746
PMCPMC2667034
OpenAlexW1988757730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.